secwatch.observer — SEC 8-K summary
======================================

Issuer:     Contineum Therapeutics, Inc. (CTNM)
CIK:        0001855175
Form:       8-K
Filed at:   2025-06-26T23:59:59+00:00
Accession:  0001437749-25-021343
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Contineum Therapeutics elects three Class I directors, ratifies EY as auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- Sarah Boyce elected with 12.7M votes for vs. 641.9K withheld; broker non-votes 2.05M.
- Troy Ignelzi elected with 13.2M votes for vs. 112.6K withheld; broker non-votes 2.05M.
- Olivia Ware elected with 12.8M votes for vs. 583.7K withheld; broker non-votes 2.05M.
- Ratification of Ernst & Young as auditor passed with 15.3M for, 53.9K against, 4.6K abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855175/000143774925021343/0001437749-25-021343-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855175/000143774925021343/ctnm20250616c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-021343

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer